D. E. Shaw & Co »

Aerovate Therapeutics shares owned by D. E. Shaw & Co

Quarter-by-quarter ownership of Aerovate Therapeutics (AVTE) shares owned by D. E. Shaw & Co from 13F filings

Historical chart of D. E. Shaw & Co investment in Aerovate Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aerovate Therapeutics held by D. E. Shaw & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aerovate Therapeutics by D. E. Shaw & Co

Quarter filed Position value Share count Share price at filing
2024-03-31 $511k 17k 29.57
2023-03-31 $322k 16k 20.17
2022-12-31 $864k 30k 29.30
2022-09-30 $569k 34k 16.59

More positions owned by D. E. Shaw & Co

Microsoft Corporation Put Option (MSFT)
Apple Put Option (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Meta Platforms Cl A Call Option (META)
Netflix Put Option (NFLX)
Chipotle Mexican Grill (CMG)
Uber Technologies Put Option (UBER)
Tesla Motors (TSLA)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Visa Com Cl A (V)
Booking Holdings (BKNG)
Pfizer Put Option (PFE)
Advanced Micro Devices Put Option (AMD)
Citigroup Com New (C)

View all positions for D. E. Shaw & Co

Top funds holding Aerovate Therapeutics

RA Capital Management
Sofinnova Ventures
TCG Crossover Management
Atlas Venture Life Science Advisors
Baker Bros. Advisors
Frazier Life Sciences Management
Cormorant Asset Management
Dr. Jeffrey R. Jay, M.D.
Driehaus Capital Management
BlackRock
Vanguard Group
OrbiMed Advisors
FMR
Eventide Asset Management
Octagon Capital Advisors

View all funds holding Aerovate Therapeutics